vs
PAVmed Inc.（PAVM）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
PAVmed Inc.的季度营收约是Arcadia Biosciences, Inc.的1.1倍（$996.0K vs $901.0K），PAVmed Inc.净利率更高（6465.8% vs -148.3%，领先6614.0%），PAVmed Inc.同比增速更快（25.9% vs -25.8%）
PAVmed Inc.是一家处于商业化阶段的医疗科技企业，专注于研发和推广创新诊断及治疗类医疗产品，业务覆盖即时诊断、介入肿瘤学、胃肠病学解决方案，主要服务美国市场的医疗机构与患者群体。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
PAVM vs RKDA — 直观对比
营收规模更大
PAVM
是对方的1.1倍
$901.0K
营收增速更快
PAVM
高出51.8%
-25.8%
净利率更高
PAVM
高出6614.0%
-148.3%
损益表 — Q3 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $996.0K | $901.0K |
| 净利润 | $64.4M | $-1.3M |
| 毛利率 | -38.7% | 21.4% |
| 营业利润率 | -1162.4% | -152.8% |
| 净利率 | 6465.8% | -148.3% |
| 营收同比 | 25.9% | -25.8% |
| 净利润同比 | 464.4% | 67.1% |
| 每股收益（稀释后） | $1.44 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PAVMRKDA
| Q4 25 | — | $901.0K | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | — | $1.5M | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $996.0K | $1.5M | ||
| Q2 24 | $979.0K | $1.3M | ||
| Q1 24 | $1.0M | $987.0K |
净利润PAVMRKDA
| Q4 25 | — | $-1.3M | ||
| Q3 25 | — | $856.0K | ||
| Q2 25 | — | $-4.5M | ||
| Q1 25 | — | $2.6M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $64.4M | $-1.6M | ||
| Q2 24 | $-10.8M | $1.1M | ||
| Q1 24 | $-15.2M | $-2.4M |
毛利率PAVMRKDA
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | -38.7% | 32.9% | ||
| Q2 24 | -70.2% | 51.5% | ||
| Q1 24 | -72.7% | 52.3% |
营业利润率PAVMRKDA
| Q4 25 | — | -152.8% | ||
| Q3 25 | — | -88.5% | ||
| Q2 25 | — | -34.4% | ||
| Q1 25 | — | 44.2% | ||
| Q4 24 | — | -187.7% | ||
| Q3 24 | -1162.4% | -114.5% | ||
| Q2 24 | -1397.8% | — | ||
| Q1 24 | -1389.7% | -160.9% |
净利率PAVMRKDA
| Q4 25 | — | -148.3% | ||
| Q3 25 | — | 65.7% | ||
| Q2 25 | — | -306.4% | ||
| Q1 25 | — | 216.6% | ||
| Q4 24 | — | -334.5% | ||
| Q3 24 | 6465.8% | -104.9% | ||
| Q2 24 | -1105.9% | 81.2% | ||
| Q1 24 | -1506.1% | -245.5% |
每股收益（稀释后）PAVMRKDA
| Q4 25 | — | $-0.97 | ||
| Q3 25 | — | $0.62 | ||
| Q2 25 | — | $-3.26 | ||
| Q1 25 | — | $1.90 | ||
| Q4 24 | — | $-2.99 | ||
| Q3 24 | $1.44 | $-1.18 | ||
| Q2 24 | $-1.19 | $0.78 | ||
| Q1 24 | $-2.62 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $765.0K | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-4.9M | $4.1M |
| 总资产 | $30.6M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PAVMRKDA
| Q4 25 | — | $4.6M | ||
| Q3 25 | — | $5.9M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $3.2M | ||
| Q4 24 | — | $4.2M | ||
| Q3 24 | $765.0K | $6.6M | ||
| Q2 24 | $25.5M | $8.1M | ||
| Q1 24 | $25.5M | $8.5M |
股东权益PAVMRKDA
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $5.4M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $8.9M | ||
| Q4 24 | — | $6.2M | ||
| Q3 24 | $-4.9M | $10.3M | ||
| Q2 24 | $-73.9M | $11.7M | ||
| Q1 24 | $-68.8M | $10.6M |
总资产PAVMRKDA
| Q4 25 | — | $6.5M | ||
| Q3 25 | — | $8.6M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $13.5M | ||
| Q3 24 | $30.6M | $15.2M | ||
| Q2 24 | $39.4M | $17.4M | ||
| Q1 24 | $37.3M | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.9M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | — |
| 自由现金流率自由现金流/营收 | -892.5% | — |
| 资本支出强度资本支出/营收 | 0.6% | 0.0% |
| 现金转化率经营现金流/净利润 | -0.14× | — |
| 过去12个月自由现金流最近4个季度 | $-45.8M | — |
8季度趋势，按日历期对齐
经营现金流PAVMRKDA
| Q4 25 | — | $-861.0K | ||
| Q3 25 | — | $-257.0K | ||
| Q2 25 | — | $-2.0M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $-8.9M | $-1.8M | ||
| Q2 24 | $-11.7M | $-2.5M | ||
| Q1 24 | $-13.1M | $-3.2M |
自由现金流PAVMRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-8.9M | — | ||
| Q2 24 | $-11.7M | $-2.5M | ||
| Q1 24 | $-13.2M | $-3.2M |
自由现金流率PAVMRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -892.5% | — | ||
| Q2 24 | -1190.9% | -188.3% | ||
| Q1 24 | -1302.1% | -326.5% |
资本支出强度PAVMRKDA
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 0.6% | 0.0% | ||
| Q2 24 | 0.3% | 0.2% | ||
| Q1 24 | 4.2% | 1.3% |
现金转化率PAVMRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.14× | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
